Explorer les evidences

218 600 000 inhabitantsBetween 2000 and 2010, the population in hyperendemic (>50% to 75% PfPR2-10) or holoendemic (>75% PfPR2-10) areas decreased from 218.6 million (34.4%) of 635.7 million to 183.5 million (22.5%) of 815.7 million across 44 malaria-endemic countries in Africa.

Kenyapaludismeobservé 2000publié 2014Lancet (London, England)europe_pmcdocument de 4 observations

45,1 %Continuous monthly spatial repellent deployment with 100% coverage caused a 45.1% reduction in malaria infections versus no spatial repellent in western Kenya.

Kenyapaludismepublié 2026Epidemiology and infectionPubMeddocument de 4 observations

0,319 odds_ratioCarriage of HbSS was associated with reduced monocytosis in children with P. falciparum malaria in Kisumu County, Western Kenya.

Kenyadrépanocytose · paludismepublié 2020BMC infectious diseasesPubMeddocument de 8 observations

A Plasmodium falciparum malaria survey in school children was conducted across eight counties in western Kenya in 2019.

Kenyapaludismeobservé 2019publié 2022Antimicrobial agents and chemotherapyeurope_pmcdocument de 5 observations

2,19 infections/person-yearThe cumulative incidence of malaria infections was 2.19 infections per person-year in the control arm.

Kenyapaludismepublié 2020The American journal of tropical medicine and hygienePubMeddocument de 2 observations

20,4 per_habitatThe high mean density of An. gambiae s.l. was 20.4 in farmland in Kakamega County, western Kenya between March and June 2019.

Kenyapaludismeobservé March and June 2019publié 2021Ethiopian journal of health sciencesPubMeddocument de 8 observations

29 parasites/µLAmong afebrile women (n = 392), the geometric-mean parasite density was 29 parasites/µL.

Kenyapaludismepublié 2022The Journal of infectious diseasesPubMeddocument de 13 observations

7,8 %Parasite prevalence by qPCR was 7.8% in Homa Bay during the wet season.

Kenyapaludismeobservé wet seasonpublié 2021BMC infectious diseasesPubMeddocument de 10 observations

56 %46 (56%) first-febrile infections were polyclonal.

Kenyapaludismepublié 2022Malaria journalPubMeddocument de 8 observations

43 %Vaccine efficacy against all episodes of clinical malaria was 43% (95% CI 28-55) in the Fx012-14-26-38 group up to month 50.

Kenyapaludismepublié 2025The Lancet. Global healthPubMeddocument de 9 observations

90 %Compliance with no anti-malarial treatment for test-negative patients ranged from 90% to 92% across surveys conducted between 2014 and 2016 in Kenya.

Kenyapaludismeobservé 2014–2016publié 2022Malaria journaleurope_pmcdocument de 5 observations

4 %The C469Y mutation declined from 4% in 2022 to 1% in 2023.

Kenyapaludismeobservé 2022publié 2025Scientific reportsPubMeddocument de 6 observations

85 %Malaria testing services were available at more than 85% of facilities.

Kenyapaludismepublié 2022Malaria journaleurope_pmcdocument de 10 observationsDOI 10.1186/s12936-022-04048-2

230 174 individualsPlasmodium falciparum prevalence data covered an examination of 230,174 individuals located in northern Namibia.

Kenyapaludismeobservé 1969–1992publié 2013PloS oneeurope_pmcdocument de 6 observations

5,4 per_1000The mean incidence of Plasmodium vivax in 2009 was 5.4 cases per 1000 population.

Kenyapaludismeobservé 2009publié 2014PloS oneeurope_pmcdocument de 7 observations

The introduction of insecticide-treated bed nets during a randomized controlled trial on the Kenyan coast significantly reduced severe, life-threatening malaria and all-cause childhood mortality.

Kenyapaludismepublié 1997Acta tropicaeurope_pmcdocument de 4 observations

8 %National malaria prevalence in Kenya was 8% in 2018.

Kenyapaludismeobservé 2018publié 2022Malaria journalPubMeddocument de 8 observations

3 foldMalaria prevalence is three-fold higher in western Kenya than the national average of 6%.

Kenyapaludismepublié 2023Malaria journalPubMeddocument de 8 observations

0,03 USDIf implemented nationally, the cost per additional child correctly managed was estimated at 0.03 USD.

Kenyapaludismeobservé 2010publié 2012PloS oneeurope_pmcdocument de 5 observations

The prevalence of sporozoite antibodies varied with age among children aged one to nine years resident in a rural area of The Gambia.

Kenyapaludismepublié 1989Annals of tropical medicine and parasitologyeurope_pmcdocument de 4 observations

29 %29% of children aged 3-59 months experienced fever within 2 weeks before the interview.

Kenyapaludismepublié 2011PLoS medicineeurope_pmcdocument de 3 observationsDOI 10.1371/journal.pmed.1000437

0,82 utility_scoreFor uncomplicated malaria, the median utility score was 0.82 using the Ethiopian value set.

Kenyapaludismeobservé June to September 2024publié 2025Health and quality of life outcomeseurope_pmcdocument de 8 observations

A single isolate from Western Kenya contained the PfK13 V568I variant, potentially linked to reduced susceptibility to artemisinin.

Kenyapaludismepublié 2024Scientific reportsPubMeddocument de 3 observations

0,7 incidence_rate_ratioIn an interim analysis of the EPI-MAL-003 study, the country-adjusted incidence rate ratio for any malaria among vaccinated children from exposed clusters compared to unvaccinated children from unexposed clusters was 0.70.

Kenyapaludismepublié 2026The Lancet. Global healthPubMeddocument de 10 observations

83,6 %In 2018, 83.6% of Plasmodium falciparum parasites in Kilifi county, Kenya carried the quintuple mutation form of sulfadoxine-pyrimethamine resistance.

Kenyapaludismeobservé 2018publié 2022Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodiumeurope_pmcdocument de 5 observations